Stocktoria
Profound Medical Corp. PROF
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2014-09-24
Chart by TradingView
5/9
Piotroski F — financial health
-3.44
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Financials | |||
| Revenue | $16.1M | $10.7M | $7.2M |
| Gross profit | $11.4M | $7.0M | $4.3M |
| Operating income | -$41.3M | -$33.1M | -$28.7M |
| Net income | -$42.6M | -$27.8M | -$28.3M |
| Operating cash flow | -$38.2M | -$23.5M | -$22.6M |
| Free cash flow | -$38.4M | — | — |
| Total assets | $77.5M | $70.2M | $44.0M |
| Total liabilities | $11.0M | $9.8M | $12.7M |
| Shareholders' equity | $66.4M | $60.4M | $31.2M |
| Ratios | |||
| Gross margin | 70.8% | 65.9% | 59.9% |
| Operating margin | -256.3% | -309.6% | -398.0% |
| Net margin | -264.4% | -260.4% | -393.4% |
| FCF margin | -238.4% | — | — |
| Return on assets | -54.9% | -39.6% | -64.4% |
| Return on equity | -64.1% | -46.0% | -90.7% |
| Debt / equity | 0.07× | 0.08× | 0.23× |
| Current ratio | 12.52 | 10.52 | 6.58 |
| Revenue growth | 50.7% | 48.4% | — |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -3.44 (distress)
- Working capital / assets 0.904
- Retained earnings / assets -3.714
- EBIT / assets -0.532
- Equity / liabilities 6.017
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001628808 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.